HayesM.A., & PickeringD.B. (1985). Comparative cytopathology of primary rat hepatocyte cultures exposed to aflatoxin B1, acetaminophen, and other hepatotoxins.Toxicology and Applied Pharmacology80, 345–357.
GoresG.J., NieminenA-L., FleischmanK.E., DawsonT.L., HermanB., & LemastersJ.J. (1988). Extracellular acidosis delays onset of cell death in ATP-depleted hepatocytes.American Journal of Physiology255, C315–C322.
8.
BorenfreundE., & PuernerJ.A. (1985). Toxicity determined in vitro by morphological alterations and neutral red absorption.Toxicology Letters24, 119–124.
9.
StadlerR., DetmarM., StephanekK., BangemannC., & OrfanosC.E. (1989). A rapid fluorometric assay for the determination of keratinocyte proliferation in vitro.Journal of Investigative Dermatology93, 532–534.
10.
SaalJ.G., RieberE.P., & RiethmullerG. (1976). Cell-mediated cytotoxicity for melanoma tumor cells: detection by a [3H]-proline release assay.Scandinavian Journal of Immunology5, 455–466.
11.
KangasL., GronroosM., & NeiminenA-L. (1984). Bioluminescence of cellular ATP: a new method for evaluating cytotoxic agents in vitro.Medical Biology62, 338–343.
12.
DenizotF., & LangR. (1986). Rapid colorimetric assay for cell growth and survival.Journal of Immunological Methods89, 271–277.
13.
PageR.A., StowellK.M., HardmanM.J., & KitsonK.E. (1992). The assessment of viability in isolated rat hepatocytes.Analytical Biochemistry200, 171–175.
14.
GilletteJ.R. (1974). A perspective on the role of chemically reactive metabolites of foreign compounds in toxicity. I. Correlation of changes in covalent binding of reactive metabolites with changes in the incidence and severity of toxicity.Biochemical Pharmacology23, 2785–2794.
15.
ShawA.J., GescherA., & MrazJ. (1988). Cytotoxicity. and metabolism of the hepatotoxin N-methylformamide and related formamides in mouse hepatocytes.Toxicology and Applied Pharmacology95, 162–170.
16.
StreeterA.J., BjorgeS.M., AxworthyD.B., NelsonS.D., & BaillieT.A. (1984). The microsomal metabolism and site of covalent binding to protein of 3-hydroxyacetanilide, a non-hepatotoxic positional isomer of acetaminophen.Drug Metabolism and Disposition12, 565–576.